fbpx

FREE2MOVE: Targets profitable growth as energy efficiency is rising on the agenda

Analys, Research

With a comprehensive offering to drastically improve the operating net for property owners, Free2Move looks to continue its strong growth...

Read More

SIMRIS ALG: Transforming to build an integrated multi-vertical microalgae and cyanobacteria company  

Analys, Research

Simris’ expanded objective to leverage the acquisition of Cyano Biotech in Q3’22, enter the high-value biopharma space and build a...

Read More

CAPSEK | Klash Studio satsar på spelstudios för att nå 80 000 kunder globalt om fem år

Okategoriserade

Göteborgsbaserade investmentbolaget Northern CapSek Ventures AB (”CapSek”) portföljbolag Klash Studio erbjuder en molntjänst som...

Read More

NANEXA: Validation from Novo Nordisk positions Nanexa for an eventful year ahead

Analys, Research

After a news packed Q4 2022, including an exclusivity and evaluation agreement with Novo Nordisk, start of Phase I with NEX-20 and two...

Read More

AGTIRA: Looking to maintain momentum into 2023

Analys, Research

Agtira closed its books for 2022 reaching record high sales of 25.5 MSEK, an 80% increase compared to 2021. While the growth was strong, we...

Read More

CRUNCHFISH: Video interview with CEO Joachim Samuelsson on ”the paradigm shift in payments” + feedback from India: ”Scale it up”

Analys, Research

https://youtu.be/kmv2PDFQQdM Read the press release from Crunchfish here READ EMERGERS’ EQUITY RESEARCH ON CRUNCHFISH HERE CRUNCHFISH:...

Read More

QLUCORE: Interview with CEO Carl-Johan Ivarsson about the important issues in 2023 and the revenue target of SEK 300 million in 2027

Analys, Research

READ EMERGERS’ EQUITY RESEARCH ON QLUCORE HERE QLUCORE: At the vanguard of both oncology research and life science M&A With a strong...

Read More

CRUNCHFISH: The most interesting fintech rollout since iZettle

Analys, Research

With the rise of digital cash, the shift to online has created a gap for users with poor or no connectivity, forcing emerging...

Read More

BONZUN: Evidence-based DTx scaling up to combat stress and infertility

Analys, Research

We re-initiate coverage on digital therapeutics (DTx) company Bonzun that offers evidence-based patient support for fertility treatments...

Read More

FOM TECHNOLOGIES: Ready for takeoff

Analys, Research

RESEARCH COLLABORATION WITH ENLIGHT RESEARCH  FOM is active in the small but fast growing market for coating solutions to the...

Read More

For new research on growth stocks, sign up to our newsletter